封面
市场调查报告书
商品编码
1587466

支架市场规模、份额和趋势分析报告:按产品、按材料、按最终用途、按地区和细分市场预测,2025-2030 年

Stents Market Size, Share & Trends Analysis Report By Product (Vascular, Non-vascular), By Material (Metallic, Non-metallic), By End-use (Hospitals, Ambulatory Care Centers, Specialty Clinics), By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

支架市场成长与趋势:

Grand View Research, Inc.最新报告显示,预计到2030年,全球支架市场规模将达到184.6亿美元,2025年至2030年复合年增长率为3.7%。

市场受到医疗设备技术持续进步的显着影响。药物释放型支架 (DES) 等技术创新彻底改变了心血管疾病的治疗模式。这些支架的设计目的是随着时间的推移释放药物,有助于防止血管再阻塞或血管成形术后血管血管再阻塞。此外,材料科学的进步促进了生物可吸收支架的发展,这种支架会随着时间的推移而溶解,从而减少与永久植入相关的长期併发症。先进的诊断影像技术和微创手术技术的整合也提高了支架置入置入术的有效性和安全性,推动了市场的成长。

全球心血管疾病(CVD)盛行率的上升推动了支架市场的扩张。久坐的生活方式、不健康的饮食以及肥胖和糖尿病的增加等因素导致冠状动脉疾病(CAD)等疾病的盛行率增加。由于心血管疾病仍然是全球发病和死亡的主要原因之一,因此对包括置入术在内的有效治疗方案的需求不断增长。人口老化进一步加剧了这一趋势,人口老化更容易患心臟相关疾病,从而增加了对介入性心臟病学解决方案的需求。

医疗保健系统的优惠报销政策鼓励医院和诊所采用更新的留置技术。这种财政支持使这些干预措施更容易获得,并激励製造商投资下一代支架产品的研发。 2024年6月,医疗技术领导者皇家飞利浦宣布首次植入双静脉支架系统。该装置核准用于治疗慢性静脉功能不全 (CVI) 患者的症状性静脉流出道阻塞,并获得美国FDA 的上市前核准。

支架市场报告亮点

  • 从产品来看,由于需要支架置入等干预措施的心血管疾病盛行率较高,血管领域在 2024 年占据最大的销售份额,达到 87.3%。支架技术的进步,例如降低血管再阻塞率的药物释放型支架,正在进一步加强血管段的地位。
  • 非血管领域预计在预测期内将以最快的复合年增长率增长,因为它适用于心血管以外的各种医疗状况,例如泌尿系统和胃肠科。
  • 从材料来看,金属支架凭藉其强度、灵活性以及即使在高压环境下也能保持通畅性的能力,在这一领域占据主导地位,到 2024 年,其市场占有率将达到 61.2%。金属支架在血管应用中特别有效,因为结构完整性对于长期成功非常重要。
  • 预计非金属支架细分市场在预测期内将以最快的复合年增长率成长。非金属支架段,包括生物分解性支架和聚合物支架,因其优点而受到关注,包括降低血栓症和发炎的风险。
  • 按最终用途划分,医院业务凭藉其完善的基础设施和先进的医疗技术,在 2024 年占据最大的收益占有率。该医院拥有专门的设施和熟练的医疗专业人员,可以执行需要放置支架的复杂手术,例如冠状动脉血管成形术。
  • 由于与传统医院相比,门诊医疗中心 (ACS) 能够以更低的成本提供门诊病人服务,因此预计在预测期内将以最快的复合年增长率成长。 ASC 提供便利和高效,使患者无需延长住院时间即可接受支架手术。
  • 由于心血管疾病(CVD)盛行率上升,2024年的市场将由北美主导。支架技术的不断创新提高了其有效性和安全性,使其对医疗保健提供者和患者都更具吸引力。预计亚太地区在预测期内将以最快的复合年增长率成长。
  • 2024 年 9 月,Renata Medical 宣布,继 8 月获得 FDA核准后,已成功在洛杉矶儿童医院的 2 岁患者体内植入 Minima Growth 支架。这是儿科先天性心臟疾病治疗的重大进步,提供了一种随患者生长的支架,解决了传统支架的限制。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场趋势及展望
  • 市场动态
  • 市场限制因素分析
  • 营商环境分析
    • SWOT 分析;按因素(政治/法律、经济/技术)
    • 波特五力分析

第四章 产品经营分析

  • 支架市场(按产品):要点
  • 支架市场:2024年及2030年产品趋势及市场占有率分析
  • 血管支架
    • 2018-2030年全球血管支架市场估计与预测
    • 冠状动脉支架
    • 外周支架
    • 神经血管支架
  • 非血管支架
    • 2018-2030年全球非血管支架市场估计与预测
    • 胃肠支架
    • 肺(气道)支架
    • 泌尿系统支架
    • 其他的

第五章 材料业务分析

  • 支架市场(依材质):要点
  • 支架市场:2024 年和 2030 年材料变动与市场占有率分析
  • 金属支架
    • 2018-2030年全球金属支架市场估计与预测
  • 非金属支架
    • 2018-2030年全球非金属支架市场估计与预测

第六章 最终用途业务分析

  • 支架市场,依最终用途:要点
  • 支架市场:2024 年和 2030 年最终用途趋势和市场占有率分析
  • 医院
    • 2018-2030 年全球医院市场估计与预测
  • 门诊护理中心 (ACS)
    • 2018-2030 年全球门诊护理中心 (ACS) 市场估计与预测
  • 专科诊所
    • 2018-2030年全球专科诊所市场估计与预测

第七章 区域业务分析

  • 区域市场简介
  • 2024 年各国市场
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东/非洲
  • 北美洲
    • 2018-2030年北美支架市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲支架市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太支架市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲支架市场,2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030年中东和非洲支架市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik SE &Co. KG
    • Biosensors International Group, Ltd.
    • Boston Scientific Corporation
    • Elixir Medical Corporation
    • Medtronic Plc
    • Meril Life Science
    • MicroPort Scientific Corporation
    • Stryker
    • Terumo Corporation
    • BD
    • WL Gore &Associates
Product Code: GVR-4-68040-163-4

Stents Market Growth & Trends:

The global stents market is anticipated to reach USD 18.46 billion by 2030 and is anticipated to grow at a CAGR of 3.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is significantly influenced by ongoing technological advancements in medical devices. Innovations such as drug-eluting stents (DES) have transformed the treatment landscape for cardiovascular diseases. These stents are designed to release medication over time, which helps to prevent restenosis, or the re-narrowing of blood vessels after angioplasty. Furthermore, advancements in materials science have led to the development of bioresorbable stents that dissolve over time, reducing long-term complications associated with permanent implants. The integration of advanced imaging techniques and minimally invasive surgical methods also enhances the efficacy and safety of stent placement procedures, thereby driving market growth.

Rising incidence of cardiovascular diseases (CVDs) globally contributes to the expansion of stents market. Factors such as sedentary lifestyles, unhealthy diets, and increasing rates of obesity and diabetes have led to a higher prevalence of conditions like coronary artery disease (CAD). As CVD remains one of the leading causes of morbidity and mortality worldwide, there is a growing demand for effective treatment options, including stenting procedures. This trend is further supported by an aging population that is more susceptible to heart-related ailments, thus propelling the need for interventional cardiology solutions.

Favorable reimbursement policies from healthcare systems encourage hospitals and clinics to adopt newer stenting technologies. This financial support makes these interventions more accessible and incentivizes manufacturers to invest in research and development for next-generation stent products. In June 2024, Royal Philips, a leader in health technology, announced the first implantation of the Duo Venous Stent System. This device, approved for treating symptomatic venous outflow obstruction in chronic venous insufficiency (CVI) patients, received premarket approval from the U.S. FDA.

Stents Market Report Highlights:

  • Based on product, vascular segment held largest revenue share of 87.3% in 2024 due to the high prevalence of cardiovascular diseases, which necessitate interventions such as stent placements. Advancements in stent technology, including drug-eluting stents that reduce restenosis rates, have further solidified the vascular segment's position.
  • Non-vascular segment is expected to grow at the fastest CAGR over the forecast period owing to its application in various medical conditions beyond cardiovascular issues, such as urology and gastroenterology.
  • Based on material, metallic stents segment dominated the segment with a market share of 61.2% in 2024 due to their strength, flexibility, and ability to maintain patency in high-pressure environments. They are particularly effective in vascular applications, where structural integrity is crucial for long-term success.
  • Non-metallic stents segment is expected to grow at the fastest CAGR over the forecast period. The non-metallic segment, including biodegradable and polymer-based stents, is gaining traction because they offer advantages such as reduced risk of thrombosis and inflammation.
  • Based on end use, hospitals segment held the largest revenue share in 2024 by end use due to their comprehensive infrastructure and advanced medical technology. Hospitals are equipped with specialized facilities and skilled healthcare professionals capable of performing complex procedures that require stent implantation, such as coronary angioplasty.
  • Ambulatory care centers (ACS) segment is expected to grow at the fastest CAGR over the forecast period owing to their ability to provide outpatient services at lower costs compared to traditional hospitals. ASCs offer convenience and efficiency, allowing patients to undergo stent procedures without the need for extended hospital stays.
  • North America dominated the market in 2024 due to rising incidence of cardiovascular diseases (CVDs). Continuous innovations in stent technology enhance their effectiveness and safety, making them more appealing to healthcare providers and patients alike. Asia Pacific is expected to grow at the fastest CAGR over the forecast period.
  • In September 2024, Renata Medical announced the successful implantation of its Minima Growth Stent in a 2-year-old patient at Children's Hospital Los Angeles, following its recent FDA approval in August. This marks a significant advancement in treating pediatric congenital heart defects, offering a stent that grows with the patient and addresses the limitations of traditional stents.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Commodity Flow Analysis
      • 1.5.1.1. Approach 1: Commodity flow approach
  • 1.6. Data Validation & Publishing
  • 1.7. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Restraint Analysis
  • 3.5. Business Environment Analysis
    • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.5.2. Porter's Five Forces Analysis

Chapter 4. Product Business Analysis

  • 4.1. Stents Market, By Product: Key Takeaways
  • 4.2. Stents Market: Product Movement & Market Share Analysis, 2024 & 2030
  • 4.3. Vascular Stents
    • 4.3.1. Global Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Coronary Stents
      • 4.3.2.1. Global Coronary Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Peripheral Stents
      • 4.3.3.1. Global Peripheral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.2. Iliac Artery Stents
        • 4.3.3.2.1. Global Iliac Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.3. Femoral Artery Stents
        • 4.3.3.3.1. Global Femoral Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.4. Carotid Artery Stents
        • 4.3.3.4.1. Global Carotid Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.5. Renal Artery Stents
        • 4.3.3.5.1. Global Renal Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.6. Other Peripheral Stents
        • 4.3.3.6.1. Global Other Peripheral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Neurovascular Stents
      • 4.3.4.1. Global Neurovascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.4.2. Intracranial Stents
        • 4.3.4.2.1. Global Intracranial Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.4.3. Flow Diverters
        • 4.3.4.3.1. Global Flow Diverters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Non-vascular Stents
    • 4.4.1. Global Non-vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Gastrointestinal Stents
      • 4.4.2.1. Global Gastrointestinal Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Biliary
        • 4.4.2.2.1. Global Biliary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. Duodenal
        • 4.4.2.3.1. Global Duodenal Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.4. Colonic
        • 4.4.2.4.1. Global Colonic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.5. Pancreatic
        • 4.4.2.5.1. Global Pancreatic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.6. Esophageal Stents
        • 4.4.2.6.1. Global Esophageal Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Pulmonary (Airway) Stents
      • 4.4.3.1. Global Pulmonary (Airway) Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.2. Silicone Airway
        • 4.4.3.2.1. Global Silicone Airway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.3. Metallic Airway
        • 4.4.3.3.1. Global Metallic Airway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Urological Stents
      • 4.4.4.1. Global Urological Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Material Business Analysis

  • 5.1. Stents Market, By Material: Key Takeaways
  • 5.2. Stents Market: Material Movement & Market Share Analysis, 2024 & 2030
  • 5.3. Metallic Stents
    • 5.3.1. Global Metallic Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Non-metallic Stents
    • 5.4.1. Global Non-metallic Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. End-Use Business Analysis

  • 6.1. Stents Market, By End-use: Key Takeaways
  • 6.2. Stents Market: End-use Movement & Market Share Analysis, 2024 & 2030
  • 6.3. Hospitals
    • 6.3.1. Global Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Ambulatory Care Centers (ACS)
    • 6.4.1. Global Ambulatory Care Centers (ACS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Specialty Clinics
    • 6.5.1. Global Specialty Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. Market Share Analysis by Country, 2024
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. MEA
  • 7.3. North America
    • 7.3.1. North America Stents Market, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. U.S. Stents Market, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Canada Stents Market, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Mexico Stents Market, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Stents Market, 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Germany Stents Market, 2018 - 2030 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. UK Stents Market, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. France Stents Market, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Italy Stents Market, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Spain Stents Market, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Denmark Stents Market, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Sweden Stents Market, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Norway Stents Market, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Stents Market, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Japan Stents Market, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. China Stents Market, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. India Stents Market, 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. South Korea Stents Market, 2018 - 2030 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Australia Stents Market, 2018 - 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Thailand Stents Market, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Stents Market, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Brazil Stents Market, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Argentina Stents Market, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Stents Market, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. South Africa Stents Market, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Saudi Arabia Stents Market, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. UAE Stents Market, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Kuwait Stents Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Profiles/Listing
    • 8.3.1. Abbott Laboratories
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. B. Braun Melsungen AG
      • 8.3.2.1. Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Biotronik SE & Co. KG
      • 8.3.3.1. Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Biosensors International Group, Ltd.
      • 8.3.4.1. Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Boston Scientific Corporation
      • 8.3.5.1. Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Elixir Medical Corporation
      • 8.3.6.1. Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Medtronic Plc
      • 8.3.7.1. Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Meril Life Science
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Platform Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. MicroPort Scientific Corporation
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Platform Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Stryker
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Platform Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Terumo Corporation
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Platform Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. BD
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Platform Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. W.L Gore & Associates
      • 8.3.13.1. Company Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Platform Benchmarking
      • 8.3.13.4. Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 4 Global Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 Global Stents Market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America Stents Market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 9 North America Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 12 U.S. Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 15 Canada Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 18 Mexico Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe Stents Market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 22 Europe Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 25 Germany Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 UK Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 27 UK Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 28 UK Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 France Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 30 France Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 31 France Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Italy Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 34 Italy Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Spain Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 37 Spain Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 40 Denmark Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 43 Sweden Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Norway Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 46 Norway Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Stents Market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 China Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 52 China Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 53 China Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Japan Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 55 Japan Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 56 Japan Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 India Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 58 India Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 59 India Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 South Korea Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 62 South Korea Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Australia Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 64 Australia Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 65 Australia Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Thailand Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 68 Thailand Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Stents Market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 72 Latin America Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 75 Brazil Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 78 Argentina Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 South Africa Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Africa Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 84 South Africa Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 UAE Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 89 UAE Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 90 UAE Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Stents Market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Stents Market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Stents Market: Product Outlook Key Takeaways
  • Fig. 15 Global Stents Market: Product Movement Analysis
  • Fig. 16 Global Vascular Stents Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Peripheral Stents Market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Neurovascular Stents Market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Non-vascular Stents Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Gastrointestinal Stents Market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Pulmonary (Airway) Stents Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Urological Stents Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 25 Global Stents Market: Material Outlook Key Takeaways
  • Fig. 26 Global Stents Market: Material Movement Analysis
  • Fig. 27 Global Metallic Stents Market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Non-metallic Stents Market, 2018 - 2030 (USD Million)
  • Fig. 29 Global Stents Market: End-use Outlook Key Takeaways
  • Fig. 30 Global Stents Market: End-use Movement Analysis
  • Fig. 31 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 32 Global Ambulatory Care Centers (ACS) Market, 2018 - 2030 (USD Million)
  • Fig. 33 Global Specialty Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Marketplace: Key Takeaways
  • Fig. 35 Regional outlook, 2024 & 2030
  • Fig. 36 Global Stents Market: Region Movement Analysis
  • Fig. 37 North America Stents Market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Stents Market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Stents Market, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico Stents Market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe Stents Market, 2018 - 2030 (USD Million)
  • Fig. 42 Germany Stents Market, 2018 - 2030 (USD Million)
  • Fig. 43 UK Stents Market, 2018 - 2030 (USD Million)
  • Fig. 44 France Stents Market, 2018 - 2030 (USD Million)
  • Fig. 45 Italy Stents Market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain Stents Market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain Stents Market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark Stents Market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden Stents Market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway Stents Market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia pacific Stents Market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan Stents Market, 2018 - 2030 (USD Million)
  • Fig. 53 China Stents Market, 2018 - 2030 (USD Million)
  • Fig. 54 India Stents Market, 2018 - 2030 (USD Million)
  • Fig. 55 Australia Stents Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea Stents Market, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand Stents Market, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America Stents Market, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil Stents Market, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina Stents Market, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa Stents Market, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa Stents Market, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia Stents Market, 2018 - 2030 (USD Million)
  • Fig. 64 UAE Stents Market, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait Stents Market, 2018 - 2030 (USD Million)